Cbdmd share price today

(YCBD)

Cbdmd share price is $0.35 & ₹29.82 as on 25 Dec 2024, 2.30 'hrs' IST

$0.35

▲

0.01

(2.28%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Cbdmd share price in Dollar and Rupees. Guide to invest in Cbdmd from India. Also see the sentimental analysis on Indian investors investing in Cbdmd. Get details on the Indian mutual funds that are investing in Cbdmd. Get Analyst recommendations and forecasts along with all the Cbdmd's financials.

Cbdmd share price movements

Today's Low: $0.35
Today's High: $0.37
$0.35
0.0%
Downside
Day's Volatility :5.15%
Upside
5.15%
52 Weeks Low: $0.31
52 Weeks High: $1.73
$0.35
11.11%
Downside
52 Weeks Volatility :82.02%
Upside
79.77%

Cbdmd Returns

Period	Cbdmd Inc	Index (Russel 2000)
3 Months	-25.53%	0.0%
6 Months	-39.4%	0.0%
1 Year	-50.7%	0.0%
3 Years	-99.28%	-21.1%

Cbdmd Key Statistics

in dollars & INR

Previous Close	$0.3422
Open	$0.35
Today's High	$0.369
Today's Low	$0.35
Market Capitalization	$2.0M
Today's Volume	$25.3K
52 Week High	$1.73
52 Week Low	$0.3111
Revenue TTM	$20.6M
EBITDA	$-4.4M
Earnings Per Share (EPS)	$-10.9
Profit Margin	-94.12%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-135.07%

How to invest in Cbdmd from India?

It is very easy for Indian residents to invest directly in Cbdmd from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cbdmd stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cbdmd or YCBD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cbdmd or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cbdmd shares which would translate to 2.434 fractional shares of Cbdmd as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cbdmd, in just a few clicks!

Returns in Cbdmd for Indian investors in Rupees

Investment Value

₹1,00,000

Cbdmd investment value today

Current value as on today

₹51,534

Returns

₹48,466

(-48.47%)

Returns from Cbdmd Stock

₹50,704 (-50.7%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Cbdmd

117%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Cbdmd on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 117% more investors are searching Cbdmd in the last 30 days versus the previous period.

Analyst Recommendation on Cbdmd

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Cbdmd(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cbdmd

What analysts predicted

Upside of 471.43%

Current:

$0.35

Target:

$2.00

Insights on Cbdmd

Price Movement
In the last 7 days, YCBD stock has moved down by -5.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 5.17M → 4.55M (in $), with an average decrease of 11.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 459.73K → -152.79K (in $), with an average decrease of 133.2% per quarter
YCBD vs HLN (1 yr)
In the last 1 year, Haleon Plc Spon Ads has given 18.8% return, outperforming this stock by 70.2%
Price to Sales
ForYCBD every $1 of sales, investors are willing to pay $0.0, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Cbdmd Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$23.7M	↑ 180.89%
Net Income	$-45.4M	↑ 10924.64%
Net Profit Margin	-192.08%	↓ 187.19%

	FY20	Y/Y Change
Revenue	$41.9M	↑ 77.09%
Net Income	$12.6M	↓ 127.74%
Net Profit Margin	30.09%	↑ 222.17%

	FY21	Y/Y Change
Revenue	$44.5M	↑ 6.2%
Net Income	$-23.4M	↓ 285.64%
Net Profit Margin	-52.6%	↓ 82.69%

	FY22	Y/Y Change
Revenue	$35.4M	↓ 20.41%
Net Income	$-74.1M	↑ 216.67%
Net Profit Margin	-209.26%	↓ 156.66%

	FY23	Y/Y Change
Revenue	$24.2M	↓ 31.77%
Net Income	$-22.9M	↓ 69.04%
Net Profit Margin	-94.96%	↑ 114.3%

	FY24	Y/Y Change
Revenue	$19.5M	↓ 19.35%
Net Income	$-3.7M	↓ 83.87%
Net Profit Margin	-18.99%	↑ 75.97%

	Q2 FY23	Q/Q Change
Revenue	$6.1M	↓ 1.93%
Net Income	$-1.8M	↓ 102.92%
Net Profit Margin	-28.93%	↓ 999.41%

	Q3 FY23	Q/Q Change
Revenue	$5.7M	↓ 6.68%
Net Income	$-15.9M	↑ 796.68%
Net Profit Margin	-277.98%	↓ 249.05%

	Q4 FY23	Q/Q Change
Revenue	$5.4M	↓ 5.87%
Net Income	$-996.5K	↓ 93.72%
Net Profit Margin	-18.54%	↑ 259.44%

	Q1 FY24	Q/Q Change
Revenue	$4.4M	↓ 18.58%
Net Income	$-4.0M	↑ 302.51%
Net Profit Margin	-91.65%	↓ 73.11%

	Q2 FY24	Q/Q Change
Revenue	$5.2M	↑ 18.22%
Net Income	$459.7K	↓ 111.46%
Net Profit Margin	8.89%	↑ 100.54%

	Q3 FY24	Q/Q Change
Revenue	$4.6M	↓ 11.94%
Net Income	$-152.8K	↓ 133.24%
Net Profit Margin	-3.35%	↓ 12.24%

	FY19	Y/Y Change
Profit	$14.5M	↑ 152.57%

	FY20	Y/Y Change
Profit	$26.4M	↑ 81.67%

	FY21	Y/Y Change
Profit	$30.0M	↑ 13.72%

	FY22	Y/Y Change
Profit	$22.3M	↓ 25.51%

	FY23	Y/Y Change
Profit	$15.0M	↓ 32.95%

	FY24	Y/Y Change
Profit	$12.0M	↓ 19.91%

	Q2 FY23	Q/Q Change
Profit	$3.8M	↓ 4.23%

	Q3 FY23	Q/Q Change
Profit	$3.5M	↓ 7.72%

	Q4 FY23	Q/Q Change
Profit	$3.3M	↓ 7.75%

	Q1 FY24	Q/Q Change
Profit	$2.6M	↓ 21.17%

	Q2 FY24	Q/Q Change
Profit	$3.4M	↑ 31.88%

	Q3 FY24	Q/Q Change
Profit	$2.5M	↓ 27.9%

	FY19	Y/Y Change
Operating Cash Flow	$-15.4M	↑ 175.92%
Investing Cash Flow	$-2.1M	↑ 212.17%
Financing Cash Flow	$17.9M	↑ 74.73%

	FY20	Y/Y Change
Operating Cash Flow	$-10.7M	↓ 30.65%
Investing Cash Flow	$-1.6M	↓ 26.42%
Financing Cash Flow	$22.4M	↑ 24.84%

	FY21	Y/Y Change
Operating Cash Flow	$-14.1M	↑ 32.15%
Investing Cash Flow	$-2.6M	↑ 62.54%
Financing Cash Flow	$28.2M	↑ 26.21%

	FY22	Y/Y Change
Operating Cash Flow	$-15.0M	↑ 6.2%
Investing Cash Flow	$-688.7K	↓ 73.01%
Financing Cash Flow	$-4.0M	↓ 114.29%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-240.6K	↓ 86.12%
Investing Cash Flow	$-102.4K	↓ 109.29%
Financing Cash Flow	$1.5M	↓ 246.69%

Cbdmd Technicals Summary

Sell

Neutral

Buy

Cbdmd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cbdmd Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cbdmd Inc	-31.1%	-39.4%	-50.7%	-99.28%	-99.68%
Neurocrine Biosciences Inc.	6.74%	1.65%	2.84%	61.59%	27.41%
Haleon Plc Spon Ads	1.56%	15.54%	17.63%	31.44%	31.44%
Zoetis Inc.	-6.26%	-6.66%	-16.35%	-33.19%	24.57%
Viatris Inc.	-5.2%	18.32%	15.13%	-9.29%	-24.11%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cbdmd Inc	NA	NA	NA	0.0	-1.35	-0.16	NA	0.8
Neurocrine Biosciences Inc.	36.41	36.41	0.32	6.37	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	29.52	29.52	1.76	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	30.96	30.96	2.56	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cbdmd Inc	Buy	$2.0M	-99.68%	NA	-94.12%
Neurocrine Biosciences Inc.	Buy	$13.8B	27.41%	36.41	17.21%
Haleon Plc Spon Ads	Buy	$44.0B	31.44%	29.52	10.75%
Zoetis Inc.	Buy	$74.3B	24.57%	30.96	26.55%
Viatris Inc.	Hold	$14.8B	-24.11%	224.4	-5.87%

About Cbdmd

cbdmd, inc. produces and distributes various cannabidiol (cbd) products. it owns and operates consumer hemp-based cbd brands, such as cbdmd and paw cbd. its cbdmd brand products include cdb tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. the company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the paw cbd brand name. it distributes its products through its e-commerce website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the united states. the company was formerly known as level brands, inc. and changed its name to cbdmd, inc. in may 2019. cbdmd, inc. was founded in 2015 and is headquartered in charlotte, north carolina.

Organization	Cbdmd
Employees	52
CEO	Mr. T. Ronan Kennedy
Industry	Other Consumer Services

Management People of Cbdmd

Name	Title
Mr. T. Ronan Kennedy	Interim CEO, CFO & Principal Executive Officer
Dr. Sibyl Swift Ph.D.	CSO, VP of Regulatory Affairs & Director
Mr. Bradley Whitford	Chief Accounting Officer, Treasurer & Secretary
Zeb Booker	Chief Technology Officer
Mr. Lance Blundell	General Counsel
Robert Pettway	Director of Public Relations
Mr. Francisco Mangual	Senior VP of Sales
Ms. Shannon Charles	Chief Marketing Officer
Mr. David Johnson	Senior VP of Business Development

Important FAQs about investing in Cbdmd from India :

What is Cbdmd share price today?

Cbdmd share price today stands at $0.35, Open: $0.35 ; Previous Close: $0.34 ; High: $0.37 ; Low: $0.35 ; 52 Week High: $1.73 ; 52 Week Low: $0.31. The stock opens at $0.35, after a previous close of $0.34. The stock reached a daily high of $0.37 and a low of $0.35, with a 52-week high of $1.73 and a 52-week low of $0.31.

Can Indians buy Cbdmd shares?

Yes, Indians can invest in the Cbdmd (YCBD) from India.

With INDmoney, you can buy Cbdmd at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cbdmd at zero transaction cost.

How can I buy Cbdmd shares from India?

It is very easy to buy Cbdmd from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cbdmd be purchased?

Yes, you can buy fractional shares of Cbdmd with INDmoney app.

What are the documents required to start investing in Cbdmd stocks?

To start investing in Cbdmd, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.